Pfizer Announces Dividend for Fourth Quarter of 2024
Pfizer Inc. (NYSE: PFE) has made a noteworthy announcement regarding its fourth-quarter dividend for 2024. The board of directors declared a dividend of $0.42 per share on the common stock. This payment, which is a continuation of its dedication to returning value to shareholders, will be available to all stockholders of record by the close of business on a specified date before the payment date. The company has a proud history of consistent dividend payments, with this marking the 344th consecutive quarterly dividend.
The Importance of Dividends
Dividends serve as a critical component of the overall returns that investors can expect from their stock investments. They provide shareholders with a way to earn passive income, and a steady flow of dividends can indicate a company’s financial health and commitment to shareholders. Pfizer’s ongoing commitment to returning capital through dividends has been a strong signal of its operational stability and profitability.
About Pfizer: A Leader in Innovative Health
Pfizer has established itself as a global leader in biopharmaceuticals, dedicated to delivering groundbreaking therapies that substantially improve patients' lives. The company harnesses advanced science and extensive resources to develop innovative medicines and vaccines that meet the needs of health care providers and patients alike.
Commitment to Patients and Healthcare
With a robust pipeline of products, Pfizer focuses on delivering quality and safety in healthcare. By collaborating with various partners, including health care providers and community organizations, Pfizer aims to expand access to affordable health care. The company’s mission emphasizes not just treatment, but the overall well-being and prevention of diseases.
Engagement with the Community
Pfizer is well aware of the responsibilities that come with being a prominent player in the pharmaceutical industry. For over 175 years, the company has been dedicated to making a positive impact on global health. This involves actively engaging with communities in both developed and emerging markets to ensure that medicines and health care are accessible to those in need.
Continuous Growth and Innovation
Innovation and growth are at the heart of Pfizer's strategy. The company continuously invests in research and development to explore new therapeutic approaches and improve existing solutions. This commitment not only benefits shareholders but also advances public health on a broader scale. By staying at the forefront of medical advancements, Pfizer is working diligently to tackle the most challenging health issues the world faces today.
Frequently Asked Questions
What is the declared dividend for Pfizer for Q4 2024?
Pfizer has declared a dividend of $0.42 per share for the fourth-quarter of 2024.
When will the dividend payout be made?
The dividend will be paid on December 2, 2024, to shareholders on record by the close of business on November 8, 2024.
How many consecutive quarterly dividends has Pfizer paid?
This will be the 344th consecutive quarterly dividend paid by Pfizer, showcasing its commitment to returning value to its shareholders.
What is Pfizer's main focus as a pharmaceutical company?
Pfizer’s main focus is on the discovery, development, and manufacture of innovative medicines and vaccines that improve patient health and quality of life.
How does Pfizer engage with the community?
Pfizer engages with communities through partnerships with healthcare providers and local organizations to expand access to affordable healthcare and support overall wellness and prevention efforts.
